Director/PDMR Shareholding

RNS Number : 2036A
Dr. Martens PLC
31 January 2022
 

Director/PDMR Shareholding

Notification of Transaction by Directors/Persons Discharging Managerial Responsibility

Dr. Martens plc (the 'Company') announces that on 31 January 2022 the following transaction(s) in the Company's ordinary shares were undertaken by directors / persons discharging managerial responsibility ('PDMRs').

The notification(s) set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

1.

Details of PDMR / person closely associated with them ('CAP')

a)

First Name

Robyn

b)

Last Name

Perriss

2.

Reasons for the notification

a)

Position / status

PDMR (Non-Executive Director)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Dr. Martens plc

b)

Legal Entity Identifier code

213800QPT8YM6NQZPH28

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of GBP 0.01 each


ISIN: GB00BL6NGV24

b)

Nature of the transaction

Acquisition of shares.

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£3.03

15,000





d)

Aggregated information

Aggregated volume

Price

 

15,000 shares

£3.03

e)

Date of the transaction

31 January 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUAUNRUAUAOAR

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings